Information Hub

Cluster of green leafy trees with sunlight beaming through

Information Centre

This area provides information on how to manage your condition and treatment with OFEV® (nintedanib).  

Welcome

This Information Centre is designed for people with PPF who have been prescribed OFEV® (nintedanib). This is a challenging time, and you’re bound to have questions and worries.

Lowercase 'i' in a circle indicating important medical information

The information provided is not a substitute for any advice given to you by your medical team or information within the patient information leaflet in your medicine pack.

This section of ‘your PPF support space’ was developed to support you during your treatment, helping you to understand your disease, manage your symptoms, know what to expect during your treatment with OFEV®, and providing you with tools and resources to help you live as well as you can.

If you have any questions after reading this information, or any further concerns, always talk to your medical team – they’re here to help you.

The Information Centre is divided into sections to support you in navigating to the information you need:

Lung icon representing the Disease information section of the page

Disease information

Jump to section
Hands holding a heart icon representing the Side effect and symptom support section of the page

Side effect and symptom support

Jump to section
Calendar icon representing the Consultation planning section of the page

Consultation planning

Jump to section
Heart and medical cross icon representing the Living with your illness section of the page

Living with your illness

Jump to section
Portrait document and information 'I' icon in a circle, representing the Additional information and resources section of the page

Additional information

Jump to section

Disease information

Lung icon representing the Disease information section of the page

Around 70,000 people in the UK live with PF – so you’re not alone. In PF, lung tissue becomes thickened, stiff and permanently scarred. This scarring is called fibrosis.

You’ve been diagnosed with a progressive form of PF, which means this scarring has shown signs of getting worse. Your illness will be referred to in this website as ‘PPF’. You may also hear your doctor use the term ‘interstitial lung disease’ (ILD); this is used to describe a large group of diseases, including PF, that involve scarring of the lungs. For most people, the cause of PF is unknown; when no cause can be found, doctors use the term ‘idiopathic pulmonary fibrosis’ (IPF).

If you want to know more about PF, IPF, or how PPF can be managed with OFEV®, follow the links below to access relevant information booklets.

How to take OFEV®

Make sure you take your medicine just as you’ve been advised by your medical team. The usual dose of OFEV® is one 150 mg soft capsule taken twice a day, about 12 hours apart. 

Please find more detailed guidance for taking your medicine appropriately below:

capsule1

Take one capsule in the morning

(e.g. with breakfast)

capsule2

Take the capsules 12 hours apart

capsule3

Take one capsule in the evening

(e.g. with dinner)

capsule4

Capsules should be taken with food, swallowed whole with water, and should not be chewed or crushed

capsule5

If you forget to take a capsule, do not take two capsules together. Take your next scheduled dose as planned

capsule6

If you take too much of your medicine, contact your medical team immediately

Lowercase 'i' in a circle indicating important medical information

Never reduce or stop your dose on your own without consulting your doctor.

Do not take OFEV®:

  • If you are pregnant,
  • If you are allergic to nintedanib, peanut or soya, or any of the other ingredients of this medicine listed in the PIL.

Talk to your doctor or pharmacist before taking Ofev if you have or have had:
liver problems, kidney problems, bleeding problems, taken blood-thinning medicines, taken pirfenidone, heart problems, recent surgery, high blood pressure, high blood pressure in the vessels of the lungs, aneurysm or artery dissections.

Possible side effects of your treatment and how to manage them

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

 

The side effects listed here are not intended to replace information with the patient information leaflet (PIL). Side effect frequency may vary depending on the condition that is being treated, please refer to the PIL for further information on side effect frequency.

Not every patient on OFEV® gets side effects, but some do. Below is a list of the potential side effects associated with OFEV®.

Very common
(May affect more than 1 in 10 people)

  • Abnormal liver test results
  • Feeling sick (nausea)
  • Loss of appetite
  • Pain in the lower body (abdomen)
  • Vomiting

Common
(May affect up to 1 in 10 people)

  • Bleeding
  • Headache
  • High blood pressure (hypertension)
  • Loss of appetite
  • Rash
  • Serious liver problems
  • Vomiting
  • Weight loss

Uncommon
(May affect up to 1 in 100 people)

  • Hair loss (alopecia)
  • Heart attack
  • High blood pressure (hypertension)
  • Increased amount of protein in your urine (proteinuria)
  • Inflammation of the large bowel
  • Itching
  • Jaundice (yellowing of the skin and whites of eyes due to high levels of bilirubin)
  • Low platelet count (thrombocytopenia)
  • Pancreatitis
  • Rash
  • Renal failure
  • Serious liver problems

Frequency unknown
(cannot be estimated from the available data)

  • An enlargement and weakening of a blood vessel wall or a tear in a blood vessel wall (aneurysms and artery dissections)
  • Hair loss (alopecia)
  • Heart attack
  • Increased amount of protein in your urine (proteinuria)
  • Jaundice (yellowing of the skin and whites of eyes due to high levels of bilirubin)
  • Pancreatitis
  • Renal failure

Side effect and symptom support

Your symptoms

Symptoms are different for each person, but here are some of the most common ones:
Weakness

Weakness

Tiredness

Tiredness

Lossofappetite

Loss of appetite

Weightloss

Weight loss

Apersistentcough

A persistent cough

that may get worse during day-to-day activities

fingertips

Widening of your fingertips

(finger chubbing) caused by lack of oxygen

Shortnessofbreath

Shortness of breath

Please read the patient information leaflet provided in your medicine pack to find out about other side effects.

Lowercase 'i' in a circle indicating important medical information

If you feel unwell or your side effects become serious, don’t wait for your next appointment: contact your healthcare team immediately.

Changing what you eat and drink can help manage the gastrointestinal side effects of OFEV®. 

More details on how your diet can help manage side effects, as well as eating and drinking well to maintain a healthy body weight, can be found in your PPF support space’s Picnic Area and in the ‘Making every mouthful count’ nutrition guide.

Older couple sat talking around a table in a sunny garden

 

Consultation planning

Your medical team

Throughout your treatment, your medical team will schedule regular appointments to see how you’re doing. Your medical team may include:

Hospital building icon with a medical cross on top, representing your hospital doctors, nurses and pharmacists, who can give you information and support.

Your hospital doctors, nurses and pharmacists, who can give you information and support.

Person walking alongside a profile of a head with brain and an apple, representing other specialists such as occupational therapists, physiotherapists, dieticians and clinical psychologists

Other specialists such as occupational therapists, physiotherapists, dieticians and clinical psychologists.
Building icon with a medical cross on top, representing your GP, practice/community nurses and local pharmacist, who can play a key role in supporting you between hospital visits

Your GP, practice/community nurses and local pharmacist, who can play a key role in supporting you between hospital visits.
Person with stethoscope around their neck next to an icon of a medical professional, representing contacting your medical team if you have taken too much medication

Doctors and nurses who specialise in managing symptoms and living well with a chronic illness.

What to tell your medical team

Your team will need to know about any medical conditions you have and what medicines you have recently taken, might take or are taking.

Medical cross icon, representing your medical conditions and medications you're taking

Doctors and nurses who specialise in managing symptoms and living well with a chronic illness.

The more your healthcare teams know about you, the better they can tailor information to your needs. For example, it can be helpful to let your healthcare teams know:

The more your healthcare teams know about you, the better they can tailor information to your needs.

How much you understand your condition

The more your healthcare teams know about you, the better they can tailor information to your needs.

If you are aware of who can help you with your condition

The more your healthcare teams know about you, the better they can tailor information to your needs.

If you know what you can do to help yourself in your day-to-day life

The more your healthcare teams know about you, the better they can tailor information to your needs.

Whether you know how your condition is managed and what your options are

The more your healthcare teams know about you, the better they can tailor information to your needs.

How confident you are in making your own decisions about your healthcare

The more your healthcare teams know about you, the better they can tailor information to your needs.

If you know what to do should you have problems managing your health

The more your healthcare teams know about you, the better they can tailor information to your needs.

How much your condition makes you feel anxious

 

It’s easy to forget to mention something important during a medical appointment. You should always try and bring a carer, family member or friend to the appointment for support, but between your visits, it can be helpful to jot down any questions you have about your health or treatment. 

Living with your illness

While there are things with PPF you can’t control, you can do a lot to help yourself live as well as possible. Leading a healthy lifestyle and taking care of both your body and your mind can make a real difference to your day-to-day well-being.

 

Healthy eating

Try to eat a healthy balanced diet with regular mealtimes and plenty of fruit and vegetables – it will boost your physical health but also help you feel more positive mentally. A balanced diet will also help keep you at the right weight, which is important as you may feel more breathless if you’re overweight. If you have noticed a change in weight, either gaining or losing, it is important to tell your medical team straightaway.

Exercise and physical activity

Regular exercise is important, as it helps you maintain muscle strength and it can improve your sleep. Exercise can also reduce depression and anxiety, so it’s good for your mental well-being too. But, of course, exercising isn’t easy when you’re breathless, so start with small steps and set yourself exercise goals.

Mental health and well-being

Your illness can take a toll on you emotionally, but there are things you can do to keep a positive outlook, and if your mental health is good, you’ll be more confident and better able to deal with stress and uncertainty.

Travelling

PPF is a challenging and unpredictable disease. However, with due caution and common sense, it should not preclude your ability to travel. 

Follow these links for handy checklists and advice to help you plan for your holiday.

Pulmonary fibrosis website

Visit website Opens in new tab

European Lung Foundation

Visit website Opens in new tab

Note: The content of the links above are hosted by a third party and not owned by Boehringer Ingelheim. The links are provided for convenience only.

Additional information

References
  1. Navaratnam V, et al. Thorax. 2011;66:462-467;

  2. NHS. Overview: Idiopathic pulmonary fibrosis. 2022. Available at: https://www.nhs.uk/conditions/idiopathic-pulmonary-fibrosis/. Last accessed: December 2023.

NP-GB-103028 | July 2024

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

 

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available. 

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

Access your progressive pulmonary fibrosis

Pulmonary fibrosis (PPF) support space

Access your progressive pulmonary fibrosis (PPF) support space

You have been directed here by your medical team because you have been prescribed OFEV® (nintedanib).

Please provide the password given to you by your medical team to access this space:

If you are unsure of your password, please contact the medical team that prescribed you OFEV® for more information.

Required.

THE INFORMATION ON THE FOLLOWING WEB PAGES IS SUITABLE AND ONLY INTENDED FOR PEOPLE LIVING IN THE UK AND IRELAND WHO HAVE BEEN PRESCRIBED OFEV®.

BY INPUTTING THE PASSWORD, YOU ARE CONFIRMING THAT YOU ARE A PATIENT PRESCRIBED THIS MEDICINE.

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available.

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

PPF support space

pulmonary fibrosis support space

Access your progressive pulmonary fibrosis (PPF) support space

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as “progressive pulmonary fibrosis” (PPF).  

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available. 

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available.

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.


NP-GB-103027 | July 2024